Yuyu Pharma (000220) — Capital Reinvestment Ratio
Yuyu Pharma (000220) has a Capital Reinvestment Ratio of 1.75x as of September 2025, meaning it reinvests 2% of its operating cash flow (₩836.62 Million) in capital expenditures (₩1.46 Billion). See Yuyu Pharma balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yuyu Pharma Capital Reinvestment Ratio (2011–2024)
This chart tracks Yuyu Pharma's Capital Reinvestment Ratio across 10 annual periods. Check Yuyu Pharma investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Yuyu Pharma (2011–2024)
Year-by-year Capital Reinvestment Ratio for Yuyu Pharma from 2011 to 2024. For live market cap and broader valuation context, see market cap of Yuyu Pharma.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | ₩24.95 Billion | ₩7.30 Billion | ▼ -97.6% |
| 2023 | 12.13x | ₩420.86 Million | ₩5.11 Billion | ▲ +800.7% |
| 2021 | 1.35x | ₩4.51 Billion | ₩6.07 Billion | ▲ +120.5% |
| 2019 | 0.61x | ₩13.19 Billion | ₩8.06 Billion | ▼ -61.8% |
| 2018 | 1.60x | ₩6.11 Billion | ₩9.76 Billion | ▼ -82.7% |
| 2017 | 9.25x | ₩561.35 Million | ₩5.19 Billion | ▲ +3819.4% |
| 2016 | 0.24x | ₩9.82 Billion | ₩2.32 Billion | ▼ -20.4% |
| 2014 | 0.30x | ₩1.36 Billion | ₩404.37 Million | ▲ +139.8% |
| 2012 | 0.12x | ₩6.51 Billion | ₩805.15 Million | ▲ +102.1% |
| 2011 | 0.06x | ₩6.67 Billion | ₩408.49 Million | — |